These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants. Vallera DA; Soderling CC; Kersey JH J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513 [TBL] [Abstract][Full Text] [Related]
45. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones. Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229 [TBL] [Abstract][Full Text] [Related]
46. Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones. Fazekas de St Groth B; Gallagher PF; Miller JF Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2594-8. PubMed ID: 3085100 [TBL] [Abstract][Full Text] [Related]
47. Molecular nature of the W3/25 and MRC OX-8 marker antigens for rat T lymphocytes: comparisons with mouse and human antigens. Thomas ML; Green JR Eur J Immunol; 1983 Oct; 13(10):855-8. PubMed ID: 6416869 [TBL] [Abstract][Full Text] [Related]
48. Distribution and mobility of murine histocompatibility H-2Kk antigen in the cytoplasmic membrane. Damjanovich S; Trón L; Szöllösi J; Zidovetzki R; Vaz WL; Regateiro F; Arndt-Jovin DJ; Jovin TM Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5985-9. PubMed ID: 6351071 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of IL 2-dependent proliferation of rat T lymphoblasts by the monoclonal antibody ART62 which reacts with MHC class 1 antigens. Osawa H; Herrmann T; Diamantstein T J Immunol; 1985 Jun; 134(6):3901-6. PubMed ID: 2580898 [TBL] [Abstract][Full Text] [Related]
50. Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit. Jay G; Palladino MA; Khoury G; Old LJ Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2654-7. PubMed ID: 6178108 [TBL] [Abstract][Full Text] [Related]
51. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo. Michaelides M; Hogarth PM; McKenzie IF Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235 [TBL] [Abstract][Full Text] [Related]
52. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing. Gromkowski SH; Heagy W; Martz E J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579 [TBL] [Abstract][Full Text] [Related]
53. Detection of a common antigen on murine B cells and Lyt-2+ T cells by a rat monoclonal antibody, 14D10. Kung JT; Sharrow SO; Mage MG; Paul WE J Immunol; 1982 Jul; 129(1):81-6. PubMed ID: 6806368 [TBL] [Abstract][Full Text] [Related]
54. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091 [TBL] [Abstract][Full Text] [Related]
55. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets. Cobbold S; Waldmann H Transplantation; 1986 May; 41(5):634-9. PubMed ID: 3085299 [TBL] [Abstract][Full Text] [Related]